<DOC>
	<DOCNO>NCT02183259</DOCNO>
	<brief_summary>To investigate bioavailability ESR 1150 CL time course determination plasma concentration ( pharmacokinetics ) no-transformed ESR 1150 single administration healthy adult male volunteer . Secondary objective investigate safety ESR 1150 CL .</brief_summary>
	<brief_title>Bioavailability , Pharmacokinetics Safety ESR 1150 CL Healthy Adult Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>healthy male subject age : &gt; = 20 &lt; = 35 year weight : &gt; = 50 &lt; = 80 kg within +/ 20 % standard weight blood pressure : systolic 100 138 mmHg diastolic less 84 mmHg pulse rate : 45 80 beat/min volunteer whose participation trial judge valid investigator base result preliminary checkup preadministration checkup history disease include cardiac , pulmonary , hepatic , renal gastrointestinal disease history drug allergy history drug dependency , alcohol dependency , etc . use trial drug within 6 month study drug administration use drug within 7 day study drug administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>